// App-Quantinova.ai

625 : Rapid Onset of Efficacy in Patients with Active Psoriatic Arthritis Treated with Ixekizumab: A Pooled Analysis of Data from Two Phase III Clinical Trials

Researchers

Presenter

  • Atul A. Deodhar

Principal Investigators

  • Kim A. Papp

  • Catherine Shuler

  • So Young Park

  • Tore K. Kvien

Medical Centers

  • Oregon Health and Science University, Portland, OR

  • K. Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada, Waterloo, ON, Canada

  • Eli Lilly and Company, Indianapolis, IN

  • Diakonhjemmet Hospital, Oslo, Norway

Locations

  • United States

  • Canada

  • Norway

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • LY2439821

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved